首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and antimycobacterial activity of prodrugs of indeno(2,1-c)quinoline derivatives.
【24h】

Synthesis and antimycobacterial activity of prodrugs of indeno(2,1-c)quinoline derivatives.

机译:茚并(2,1-c)喹啉衍生物的前药的合成及其抗分枝杆菌活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Recently we have reported anti-TB properties of a new class of conformationally-constrained indeno[2,1-c]quinolines, which are although considerably active (MIC 0.39-0.78 mug/mL) suffered from intense solubility problems. We thought of improving their bioavailability by prodrugs approach. Accordingly esters of the "Lead" indeno[2,1-c]quinolines 1, 15 and 27 derivatives were synthesized and their prodrug nature at the physiological pH were confirmed. Prodrugs were evaluated for their antimycobacterial activity against Mycobacterium tuberculosis H37Rv by MABA assay to show that they have 2- to 4-fold improved anti-TB activities, increased aqueous solubility and superior selectivity index over their respective parent compounds. MIC of these prodrugs was in the range of <0.20-6.0 mug/mL, and in general, no cytotoxicity was observed in VERO cells.
机译:最近,我们报道了一类新的受构象约束的茚并[2,1-c]喹啉的抗结核病特性,尽管它们的活性很高(MIC 0.39-0.78 mug / mL),但存在严重的溶解性问题。我们考虑通过前药方法提高其生物利用度。因此,合成了“铅”茚并[2,1-c]喹啉1、15和27衍生物的酯,并确认了它们在生理pH下的前药性质。通过MABA分析评估了前药对结核分枝杆菌H37Rv的抗分枝杆菌活性,显示它们比其各自的母体化合物具有2至4倍的改进的抗TB活性,增加的水溶性和优良的选择性指数。这些前药的MIC在<0.20-6.0马克杯/毫升的范围内,并且通常在VERO细胞中未观察到细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号